Navigation Links
VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
Date:11/12/2009

continue to be very pleased with the rapidly expanding capability and adoption of our fluorescence agents and FMT imaging systems as a standard in measuring key biologic pathways and biomarkers in vivo," said Kirtland Poss, President and CEO of VisEn. "We look forward to working further with our customers in advancing their research and therapeutic development in these important disease areas."

VisEn's proprietary fluorescence imaging agents and labels are designed to provide the industry's broadest and most robust range of biologically-specific imaging readouts in vivo. VisEn offers over 30 different fluorescence molecular agents for imaging key disease-associated biologic targets, processes and pathways. VisEn agent brands include ProSense®, IntegriSense(TM), AngioSense(TM), OsteoSense®, MMPSense(TM), Cat K FAST(TM), Annexin-Vivo(TM), and now ReninSense FAST and Cat B FAST. VisEn also offers specialized lines of in vivo agent labeling platforms, including its proprietary VivoTag® fluorescence labeling dyes for custom agent development and its NanoSpark® labeling nanoparticles. They are all designed and optimized specifically for superior biocompatibility, brightness, stability and performance in in vivo imaging.

All VisEn agents and labels are designed for in vivo biomarker quantification using VisEn's Fluorescence Molecular Tomography (FMT(TM)) imaging systems, or for general use along with other non-quantitative fluorescence in vivo imaging systems. VisEn agents are also designed to enable complementary in vitro biomarker readouts in cells and tissues using standard fluorescence microscopy and cellular-based imaging systems. With a focus on translational research and results, all of VisEn's technologies are designed to generate translational data linking pre-clinical research into clinical medicine.

About VisEn Medical Inc.
'/>"/>

SOURCE VisEn Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
2. VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and ... report to their offering. A ... and geography) - Size, Share, Global Trends, Company ... and Forecast, 2013 - 2020", suggests that the ...
(Date:8/20/2014)... ALBANY, New York , August 20, 2014 /PRNewswire/ ... published a new market report titled "Monochloroacetic Acid (MCA) ... Other Applications - Global Industry Analysis, Size, Share, Growth, ... acid market was valued at USD 817.1 million in ... by 2020, growing at a CAGR of 3.6% during ...
(Date:8/20/2014)... Research and Markets has ... Wound Care and Closure Market (Types, Applications, End ... Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, ... to their offering. The new ... market (types, applications, end user and geography) - ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2
... MINNETONKA, Minn. , July 14 American ... provider of world-class devices and therapies for both male and ... study on their market leading MiniArc Single-Incision Sling System for ... MiniArc efficacy rates for negative cough stress test (CST) and ...
... and TULSA, Okla. , July 14 ... strategic alliance to increase the availability of important new ... These tests and the GeneMedRx medication management software can ... personalize their prescribing practices in order to prevent adverse ...
Cached Medicine Technology:12-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 212-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 3Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation 2
(Date:8/21/2014)... Inc. magazine ranked Centurion Service Group No. 3745 ... of the nation's fastest-growing private companies. The list represents ... of the economy—America’s independent entrepreneurs. Companies such as Yelp, ... other well-known names gained early exposure as members of ... been named to the Inc. 5000 list. We have ...
(Date:8/21/2014)... Sometimes you have to lose the life of ... “From Zero to a Hundred: Finding My Purpose through My Pain,” ... surviving a broken family, a childhood of gang violence and two ... were created to be,” Roy said. “I didn’t give up on ... my purpose today of helping others overcome their trials.” , He ...
(Date:8/21/2014)... NM (PRWEB) August 21, 2014 ... by the Centers for Disease Control and Prevention ... in assessing their compliance with the immunization standards ... and the CDC's General Recommendations on Immunizations. , ... of the many procedures in place to protect ...
(Date:8/21/2014)... August 21, 2014 InSilico ... interventions and addressing the challenges of a ... OncoFinder, for signalome-wide pathway analysis. This ... cross-platform analysis of gene expression data obtained ... published in the journal Frontiers in Molecular ...
(Date:8/20/2014)... August 21, 2014 Most people think ... summer months often get overlooked for a variety of ... for food pantries. Understanding this need, Dr. Bryne ... & natural health care center, wanted to heighten awareness ... hosted its first annual Thanksgiving in July food drive ...
Breaking Medicine News(10 mins):Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:ACC Health Raises the Bar Again by Completing the CQIIP Certification Program 2Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2
... The American College of Preventive Medicine (ACPM), a national ... physicians who administer individual and community immunization programs, has ... content of its program, Eli Stone, which suggests a ... The show is scheduled to air Thursday, January 31. ...
... AFL ) today reported its fourth quarter results., ... to the,dollar in the fourth quarter, rising 9.0% to ... of 2006. Net earnings were $382 million,or $.78 per ... share, a,year ago. Net earnings included realized investment losses ...
... for food, sex , , WEDNESDAY, Jan. 30 (HealthDay News) ... in drug addicts, even if they,re unaware that they,ve ... by the U.S. National Institute on Drug Abuse (NIDA). ... to monitor brain activity in cocaine-addicted patients while drug-related ...
... preserving Blue Cross,s nonprofit mission gives Michigan ... LANSING, Mich., Jan. 30 Creation of ... people rejected by,commercial insurers and HMOs because of ... the Michigan Senate Health Policy Committee,today. The Senate ...
... SYK ) announced today that it will participate in the ... - 2:20 p.m. Eastern Time 2008 ... Device Conference New York, New ... available,on Stryker,s website at http://www.stryker.com via the For Investors ...
... a pediatric neurologist at The Childrens Hospital of ... Medicine, has been named a Howard Hughes Medical ... 2007, Cheung was one of 15 physician-scientists selected ... Like all those chosen, Dr. Cheung focuses on ...
Cached Medicine News:Health News:Aflac Incorporated Announces Fourth Quarter Results 2Health News:Aflac Incorporated Announces Fourth Quarter Results 3Health News:Aflac Incorporated Announces Fourth Quarter Results 4Health News:Aflac Incorporated Announces Fourth Quarter Results 5Health News:Aflac Incorporated Announces Fourth Quarter Results 6Health News:Aflac Incorporated Announces Fourth Quarter Results 7Health News:Aflac Incorporated Announces Fourth Quarter Results 8Health News:Aflac Incorporated Announces Fourth Quarter Results 9Health News:Aflac Incorporated Announces Fourth Quarter Results 10Health News:Aflac Incorporated Announces Fourth Quarter Results 11Health News:Aflac Incorporated Announces Fourth Quarter Results 12Health News:Aflac Incorporated Announces Fourth Quarter Results 13Health News:Drug-Related Images Trigger Brain's Reward Center 2Health News:Blue Cross Blue Shield of Michigan Says Guaranteed Access Provisions of Insurance Reform Bills Protect Michigan Consumers Twice-Over 2Health News:Blue Cross Blue Shield of Michigan Says Guaranteed Access Provisions of Insurance Reform Bills Protect Michigan Consumers Twice-Over 3Health News:Stryker to Present at Investor Conference 2Health News:Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator 2
The Sutura family of products is designed to allow interventionalists to perform vessel closure from 6F up to 24F. It's elegant design allows one-handed use through sheath, routinely eliminating need...
The Closer vascular closure device is a suture mediated closure system. It has a sheath-like profile and easy positioning. It has an innovative design which involves the needles outside the artery an...
Spyglass angiography catheters, combined with St. Jude Medical hemostasis introducers and GuideRight guidewires, offer a safe and effective diagnostic angiography system....
Jography angiographic catheter has a new material combination, a patented angled weld, a flat wire braid design with a XXL lumen. It also has an atraumatic soft tip....
Medicine Products: